Advertisement

Chronic Kidney Disease–Mineral-Bone Disorder: A New Paradigm

      Disturbances in mineral and bone metabolism are prevalent in chronic kidney disease (CKD) and an important cause of morbidity, decreased quality of life, and extraskeletal calcification that have been associated with increased cardiovascular mortality. These disturbances have traditionally been termed renal osteodystrophy and classified on the basis of bone biopsy. Kidney Disease: Improving Global Outcomes (KDIGO) recently sponsored a Controversies Conference to evaluate this definition. The recommendations were that (1) the term renal osteodystrophy be used exclusively to define alterations in bone morphology associated with CKD and (2) the term CKD–mineral and bone disorder (CKD-MBD) be used to describe the broader clinical syndrome that develops as a systemic disorder of mineral and bone metabolism as a result of CKD. CKD-MBD is manifested by an abnormality of any one or a combination of the following: laboratory—abnormalities of calcium, phosphorus, PTH, or vitamin D metabolism; bone—changes in bone turnover, mineralization, volume, linear growth, or strength; and calcification—vascular or other soft-tissue calcification. The pathogenesis and clinical manifestations of these components of CKD-MBD are described in detail in this issue of Advances in Chronic Kidney Disease.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eknoyan G.
        • Lameire N.
        • Barsoum R.
        • et al.
        The burden of kidney disease: Improving global outcomes.
        Kidney Int. 2004; 66: 1310-1314
        • Foley R.N.
        • Parfrey P.S.
        • Sarnak M.J.
        Clinical epidemiology of cardiovascular disease in chronic renal disease.
        Am J Kidney Dis. 1998; 32: S112-S119
        • National Kidney Foundation Task Force on Cardiovascular Disease
        Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here?.
        Am J Kidney Dis. 1998; 32: S1-S199
        • Parekh R.S.
        • Carroll C.E.
        • Wolfe R.A.
        • et al.
        Cardiovascular mortality in children and young adults with end-stage kidney disease.
        J Pediatr. 2002; 141: 191-197
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • et al.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Cheung A.K.
        • Sarnak M.J.
        • Yan G.
        • et al.
        Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.
        Kidney Int. 2000; 58: 353-362
        • Moe S.M.
        • Chen N.X.
        Pathophysiology of vascular calcification in chronic kidney disease.
        Circ Res. 2004; 95: 560-567
        • Moe S.
        • Drueke T.
        • Cunningham J.
        • et al.
        Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
        Kidney Int. 2006; 69: 1945-1953
        • Block G.A.
        • Klassen P.S.
        • Lazarus J.M.
        • et al.
        Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
        J Am Soc Nephrol. 2004; 15: 2208-2218
        • Young E.W.
        • Albert J.M.
        • Satayathum S.
        • et al.
        Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.
        Kidney Int. 2005; 67: 1179-1187
        • Noordzij M.
        • Korevaar J.C.
        • Boeschoten E.W.
        • et al.
        The Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline for bone metabolism and disease in CKD: Association with mortality in dialysis patients.
        Am J Kidney Dis. 2005; 46: 925-932
        • Stevens L.A.
        • Djurdjev O.
        • Cardew S.
        • et al.
        Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes.
        J Am Soc Nephrol. 2004; 15: 770-779
        • Moe S.M.
        • Chertow G.M.
        The case against calcium-based phosphate binders.
        Clin J Am Soc Nephrol. 2006; 1: 697-703
        • Slinin Y.
        • Foley R.N.
        • Collins A.J.
        Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study.
        J Am Soc Nephrol. 2005; 16: 1788-1793
        • London G.M.
        • Guerin A.P.
        • Marchais S.J.
        • et al.
        Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality.
        Nephrol Dial Transplant. 2003; 18: 1731-1740
        • Merjanian R.
        • Budoff M.
        • Adler S.
        • et al.
        Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease.
        Kidney Int. 2003; 64: 263-271
        • Tonelli M.
        • Sacks F.
        • Pfeffer M.
        • et al.
        Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.
        Circulation. 2005; 112: 2627-2633
        • Seibert E.
        • Levin N.W.
        • Kuhlmann M.K.
        Immunomodulating effects of vitamin D analogs in hemodialysis patients.
        Hemodial Int. 2005; 9: S25-S29
        • Peterlik M.
        • Cross H.S.
        Vitamin D and calcium deficits predispose for multiple chronic diseases.
        Eur J Clin Invest. 2005; 35: 290-304
        • Holick M.F.
        Vitamin D for health and in chronic kidney disease.
        Semin Dial. 2005; 18: 266-275
        • Teng M.
        • Wolf M.
        • Lowrie E.
        • et al.
        Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
        N Engl J Med. 2003; 349: 446-456
        • Teng M.
        • Wolf M.
        • Ofsthun M.N.
        • et al.
        Activated injectable vitamin D and hemodialysis survival: A historical cohort study.
        J Am Soc Nephrol. 2005; 16: 1115-1125
        • Achinger S.G.
        • Ayus J.C.
        The role of vitamin D in left ventricular hypertrophy and cardiac function.
        Kidney Int. 2005; : S37-S42
        • LaClair R.E.
        • Hellman R.N.
        • Karp S.L.
        • et al.
        Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States.
        Am J Kidney Dis. 2005; 45: 1026-1633
        • Gonzalez E.A.
        • Sachdeva A.
        • Oliver D.A.
        • et al.
        Vitamin D insufficiency and deficiency in chronic kidney disease: A single center observational study.
        Am J Nephrol. 2004; 24: 503-510
        • Thomas M.K.
        • Lloyd-Jones D.M.
        • Thadhani R.I.
        • et al.
        Hypovitaminosis D in medical inpatients.
        N Engl J Med. 1998; 338: 777-783
        • Stehman-Breen C.O.
        • Sherrard D.J.
        • Alem A.M.
        • et al.
        Risk factors for hip fracture among patients with end-stage renal disease.
        Kidney Int. 2000; 58: 2200-2205
        • Alem A.M.
        • Sherrard D.J.
        • Gillen D.L.
        • et al.
        Increased risk of hip fracture among patients with end-stage renal disease.
        Kidney Int. 2000; 58: 396-399
        • Coco M.
        • Rush H.
        Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.
        Am J Kidney Dis. 2000; 36: 1115-1121
        • Danese M.D.
        • Kim J.
        • Doan Q.V.
        • et al.
        PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
        Am J Kidney Dis. 2006; 47: 149-156
        • Atsumi K.
        • Kushida K.
        • Yamazaki K.
        • et al.
        Risk factors for vertebral fractures in renal osteodystrophy.
        Am J Kidney Dis. 1999; 33: 287-293
        • Ibels L.S.
        • Alfrey A.C.
        • Huffer W.E.
        • et al.
        Arterial calcification and pathology in uremic patients undergoing dialysis.
        Am J Med. 1979; 66: 790-796
        • Schwarz U.
        • Buzello M.
        • Ritz E.
        • et al.
        Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.
        Nephrol Dial Transplant. 2000; 15: 218-223
        • Braun J.
        • Oldendorf M.
        • Moshage W.
        • et al.
        Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.
        Am J Kidney Dis. 1996; 27: 394-401
        • Guerin A.P.
        • London G.M.
        • Marchais S.J.
        • et al.
        Arterial stiffening and vascular calcifications in end-stage renal disease.
        Nephrol Dial Transplant. 2000; 15: 1014-1021
        • Goodman W.G.
        • Goldin J.
        • Kuizon B.D.
        • et al.
        Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.
        N Engl J Med. 2000; 342: 1478-1483
        • Mehrotra R.
        • Budoff M.
        • Christenson P.
        • et al.
        Determinants of coronary artery calcification in diabetics with and without nephropathy.
        Kidney Int. 2004; 66: 2022-2031
        • Block G.A.
        • Spiegel D.M.
        • Ehrlich J.
        • et al.
        Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.
        Kidney Int. 2005; 68: 1815-1824
        • Hujairi N.M.
        • Afzali B.
        • Goldsmith D.J.
        Cardiac calcification in renal patients: What we do and don’t know.
        Am J Kidney Dis. 2004; 43: 234-243
        • McCullough P.A.
        • Sandberg K.R.
        • Dumler F.
        • et al.
        Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: A systematic review.
        J Nephrol. 2004; 17: 205-215
        • Taylor A.J.
        • Bindeman J.
        • Feuerstein I.
        • et al.
        Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: Mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project.
        J Am Coll Cardiol. 2005; 46: 807-814
        • Arad Y.
        • Goodman K.J.
        • Roth M.
        • et al.
        Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events the St.
        J Am Coll Cardiol. 2005; 46: 158-165
        • Moe S.M.
        • O’Neill K.D.
        • Reselerova M.
        • et al.
        Natural history of vascular calcification in dialysis and transplant patients.
        Nephrol Dial Transplant. 2004; 19: 2387-2393
        • Matsuoka M.
        • Iseki K.
        • Tamashiro M.
        • et al.
        Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.
        Clin Exp Nephrol. 2004; 8: 54-58
        • Wang A.Y.
        • Wang M.
        • Woo J.
        • et al.
        Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study.
        J Am Soc Nephrol. 2003; 14: 159-168
        • Yuen D.
        • Pierratos A.
        • Richardson R.M.
        • et al.
        The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients.
        Nephrol Dial Transplant. 2006; 21: 1407-1412
        • Adragao T.
        • Pires A.
        • Lucas C.
        • et al.
        A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
        Nephrol Dial Transplant. 2004; 19: 1480-1488
        • Chesterton L.J.
        • Sigrist M.K.
        • Bennett T.
        • et al.
        Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness.
        Nephrol Dial Transplant. 2005; 20: 1140-1147
        • Blacher J.
        • Guerin A.P.
        • Pannier B.
        • et al.
        Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.
        Hypertension. 2001; 38: 938-942
        • Klassen P.S.
        • Lowrie E.G.
        • Reddan D.N.
        • et al.
        Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.
        JAMA. 2002; 287: 1548-1555
        • Goodman W.G.
        • London G.
        • Amann K.
        • et al.
        Vascular calcification in chronic kidney disease.
        Am J Kidney Dis. 2004; 43: 572-579
        • Wexler L.
        • Brundage B.
        • Crouse J.
        • et al.
        • Writing Group
        Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications.
        Circulation. 1996; 94: 1175-1192
        • Hutchison A.J.
        • Whitehouse R.W.
        • Boulton H.F.
        • et al.
        Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.
        Kidney Int. 1993; 44: 1071-1077
        • London G.M.
        • Marty C.
        • Marchais S.J.
        • et al.
        Arterial calcifications and bone histomorphometry in end-stage renal disease.
        J Am Soc Nephrol. 2004; 15: 1943-1951
        • Kurz P.
        • Monier-Faugere M.C.
        • Bognar B.
        • et al.
        Evidence for abnormal calcium homeostasis in patients with adynamic bone disease.
        Kidney Int. 1994; 46: 855-861
        • Chertow G.M.
        • Burke S.K.
        • Raggi P.
        Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
        Kidney Int. 2002; 62: 245-252
        • Raggi P.
        • James G.
        • Burke S.K.
        • et al.
        Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
        J Bone Miner Res. 2005; 20: 764-772
        • Parfitt A.M.
        • Drezner M.K.
        • Glorieux F.H.
        • et al.
        Bone histomorphometry: standardization of nomenclature, symbols, and units.
        J Bone Miner Res. 1987; 2: 595-610
        • Gal-Moscovici A.
        • Sprague S.M.
        Bone health in chronic kidney disease–mineral and bone disease.
        Adv Chronic Kidney Dis. 2007; 14: 27-36
        • Cunningham J.
        • Sprague S.M.
        • Cannata-Andia J.
        • et al.
        Osteoporosis in chronic kidney disease.
        Am J Kidney Dis. 2004; 43: 566-571